More SEC Filings
View Older Stories View Newer Stories-
Form 4 CrowdStrike Holdings, For: Mar 20 Filed by: OLEARY DENIS
-
Form 4 Delek US Holdings, Inc. For: Mar 19 Filed by: Zohar Shlomo
-
Form 4 Aura Minerals Inc. For: Mar 19 Filed by: Barbosa Rodrigo Cardoso
-
Form 4 NEXSTAR MEDIA GROUP, For: Mar 19 Filed by: WEITMAN GARY
-
Form 4 FIVE BELOW, INC For: Mar 19 Filed by: Park Winifred
-
Form 4 Better Home & Finance For: Mar 23 Filed by: Spencer Vance
-
Form 4 NEXSTAR MEDIA GROUP, For: Mar 19 Filed by: Russell Blake
-
Form 4 NEXSTAR MEDIA GROUP, For: Mar 19 Filed by: Morgan Rachel
-
Form 4 FIVE BELOW, INC For: Mar 19 Filed by: Israel Michelle Lee
-
Form 4 NEXSTAR MEDIA GROUP, For: Mar 19 Filed by: Jenkins Brett
-
Form 4 FIVE BELOW, INC For: Mar 19 Filed by: Sullivan Daniel
-
Form 4 FIVE BELOW, INC For: Mar 19 Filed by: SPECTER ERIC M
-
Form 4 NEXSTAR MEDIA GROUP, For: Mar 19 Filed by: Lanzano Dan
-
Form SCHEDULE 13D/A UNIVERSAL SAFETY PRODUCT Filed by: Hyperscale Data, Inc.
-
Form 4 FIVE BELOW, INC For: Mar 19 Filed by: Jhunjhunwala Amit
-
Form 4 IONIS PHARMACEUTICALS For: Mar 19 Filed by: Schneider Eugene
-
Form 4 NEXSTAR MEDIA GROUP, For: Mar 19 Filed by: ZIMMER DANA
-
Form 4 FIVE BELOW, INC For: Mar 19 Filed by: Gellerman Maureen Marie
-
Form 4 NEXSTAR MEDIA GROUP, For: Mar 19 Filed by: COMPTON SEAN
-
Form 4 FIVE BELOW, INC For: Mar 19 Filed by: Poliner Graham
-
Form 4 FIVE BELOW, INC For: Mar 19 Filed by: BULL KENNETH R
-
Form 4 NEXSTAR MEDIA GROUP, For: Mar 19 Filed by: ALFORD ANDREW
-
Form 4 NEXSTAR MEDIA GROUP, For: Mar 19 Filed by: Gliha Lee Ann
-
Form 4 NEXSTAR MEDIA GROUP, For: Mar 19 Filed by: Biard Michael
-
Form 3 ASCENTAGE PHARMA GROUP For: Mar 18 Filed by: Wei Ren
-
Form 4 ORASURE TECHNOLOGIES For: Mar 20 Filed by: McGrath Kenneth J
-
Form 4 ORASURE TECHNOLOGIES For: Mar 20 Filed by: EGLINTON MANNER CARRIE
-
Form 3/A ASCENTAGE PHARMA GROUP For: Mar 18 Filed by: Ye Changqing
-
Form 3/A ASCENTAGE PHARMA GROUP For: Mar 18 Filed by: Yu Debra
-
Form 3/A ASCENTAGE PHARMA GROUP For: Mar 18 Filed by: Lu Simon Dazhong
-
Form 3/A ASCENTAGE PHARMA GROUP For: Mar 18 Filed by: Lu Simon Dazhong
-
Form 4 Adaptive Biotechnologies For: Mar 19 Filed by: RUBINSTEIN JULIE
-
Form 4 Atlanticus Holdings Corp For: Mar 19 Filed by: Saunders Mitchell
-
Form 4 AN2 Therapeutics, Inc. For: Mar 19 Filed by: Day Lucy
-
Form 4 Atlanticus Holdings Corp For: Mar 19 Filed by: Howard Jeffrey A.
-
Form 4 AN2 Therapeutics, Inc. For: Mar 19 Filed by: Chanda Sanjay
-
Form 4 Atlanticus Holdings Corp For: Mar 19 Filed by: McCamey William
-
Form 3/A ASCENTAGE PHARMA GROUP For: Mar 18 Filed by: SIDRANSKY DAVID
-
Form 4 AN2 Therapeutics, Inc. For: Mar 19 Filed by: Marks Gilbert Lynn
-
Form 3 ASCENTAGE PHARMA GROUP For: Mar 18 Filed by: Wang Shaomeng
-
Form 3/A ASCENTAGE PHARMA GROUP For: Mar 18 Filed by: LIPPMAN MARC E
-
Form 3 ASCENTAGE PHARMA GROUP For: Mar 18 Filed by: Knapp Thomas J
-
Form 4 AN2 Therapeutics, Inc. For: Mar 19 Filed by: Aziz Kabeer
-
Form 4 AN2 Therapeutics, Inc. For: Mar 19 Filed by: Martin Patricia A.
-
Form 4 AN2 Therapeutics, Inc. For: Mar 19 Filed by: FitzPatrick Margaret M
-
Form 4 ACI WORLDWIDE, INC. For: Mar 19 Filed by: deBeers Kimberly A.
-
Form 4 AN2 Therapeutics, Inc. For: Mar 19 Filed by: Wong Stephanie
-
Form 4 AN2 Therapeutics, Inc. For: Mar 19 Filed by: Zakrzewski Joseph S
-
Form 144 Dell Technologies Inc. Filed by: Silver Lake Technology Investors V, L.P.
-
Form 4 AN2 Therapeutics, Inc. For: Mar 19 Filed by: Eizen Joshua M

